NICE to adopt orphan drugs

From April 2013, NICE, the health technology appraisal institute for England and Wales, will take on the task of appraising orphan medicines. The news may worry some companies given the criticism levelled at NICE over its assessments of rare and end-of-life cancer treatments. However, it looks likely that NICE will be taking note of existing procedures for assessing such drugs and adapting its processes.